FROVA® has a long elimination half-lifea
aA correlation between elimination half-life and clinical effect has not been established.
Amerge® (naratriptan HCI) and Imitrex® (sumatriptan succinate) are registered trademarks of GlaxoSmithKline. Axert® (almotriptan malate) is a registered trademark of Ortho-McNeil Pharmaceutical, Inc. Maxalt® (rizatriptan benzoate) is a registered trademark of Merck & Co., Inc. Relpax® (eletriptan hydrobromide) is a registered trademark of Pfizer Inc. Zomig® (zolmitriptan) is a registered trademark of the AstraZeneca group of companies.
